Treatment of NCSE depends to a large extent on the subtype diagnosed and the circumstances in which SE occurs ( Table 1). The drug regimens described below are applicable to patients of all ages ...

Following the reverse share split, the Company will have approximately 534,600 outstanding shares, out of which approximately 516,727 will be publicl ...

SciSparc Ltd. ("SciSparc" or the "Company") (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies ...

Status epilepticus: A prolonged seizure (usually defined as lasting longer than 5 minutes) or a series of repeated seizures without regaining consciousness.

Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.

Learn how first-line antiepileptic drugs, personalized care, and lifestyle changes work together to manage generalized ...

Nonconvulsive status epilepticus (NCSE) encompasses a wide range of diagnoses with variable outcomes and treatment recommendations. In children, NCSE can be observed in various conditions ...

Technology will soon make it possible to develop cheap, widely accessible psychoactive substances that are not harmful in the ...

The FDA has granted Orphan Drug designation to riliprubart for the investigational treatment of AMR in solid organ transplantation.

Capricor Therapeutics' Deramiocel earns Orphan Drug status for Becker muscular dystrophy. Read more here.

The Trump administration will revoke the legal status and work permits of hundreds of thousands of Haitian migrants in early September.

(RTTNews) - The U.S. Food and Drug Administration has granted orphan drug designation to riliprubart for the investigational treatment of antibody-mediated rejection (AMR) in solid organ ...